Reveal the Prevalence of Anti-Hepatitis B Core and its Importance among Hemodialysis Patients in Hodeidah City | ||||
Benha Journal of Applied Sciences | ||||
Article 31, Volume 6, Issue 3, May and June 2021, Page 187-193 PDF (908.58 K) | ||||
Document Type: Original Research Papers | ||||
DOI: 10.21608/bjas.2021.188841 | ||||
![]() | ||||
Authors | ||||
E.M. El-Morsy1; A.A. El-baially2; S.M. Alghalibi3; M.E. Khalifah1; K.A. Baddah4 | ||||
1Botany, Dept., Faculty of Science, Damietta Univ., Damietta, Egypt | ||||
2Microbiology and Immunology, Dept., Faculty of Medicine, Zagazig Univ., Zagazig, Egypt | ||||
3Microbiology and Immunology, Dept., Faculty of Science, Sana’a Univ., Sana’a, Yemen | ||||
4Medical laboratories, Faculty of medicine and health Sciences, Hodeidah Univ., Hodeidah, Yemen | ||||
Abstract | ||||
Hepatitis B is a dangerous illness and simple blood transportation and other ways, particularly in patients with chronic hemodialysis (HD). HBV has significant pathogenicity and mortality rates. The objective of this experiment was to assess the rates of anti-HBc distribution among chronic HD patients in Hodeidah City. This investigation was applied to 150 chronic HD patients and soon before HD sessions, samples were obtained. All samples have been analysed using ELISA for anti-HBc. Sera, which has shown that anti-HBc is positive, were tested for liver function. The ages of 30 to 50y (40,7 percent) were the most vulnerable and statistically significant to the HD process (P < 0,05). Of 150, 129 (86.0 percent) were anti-HBcAg positive. Conclusions: significant anti-HBc distribution rate among HD patients in the city of Hodeidah. | ||||
Keywords | ||||
chronic HD patients; Anti-Hepatitis B core (anti-HBc) | ||||
Statistics Article View: 116 PDF Download: 386 |
||||